245 related articles for article (PubMed ID: 29291425)
1. Lymphangitic Carcinomatosis From Prostate Cancer Identified With Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography Imaging.
Tang VD; Campbell P; Pattison DA
Urology; 2018 Apr; 114():e1-e2. PubMed ID: 29291425
[TBL] [Abstract][Full Text] [Related]
2. Lymphangitic carcinomatosis from prostate carcinoma.
Wu JW; Chiles C
J Comput Assist Tomogr; 1999; 23(5):761-3. PubMed ID: 10524863
[No Abstract] [Full Text] [Related]
3. FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis.
Prakash P; Kalra MK; Sharma A; Shepard JA; Digumarthy SR
AJR Am J Roentgenol; 2010 Jan; 194(1):231-6. PubMed ID: 20028927
[TBL] [Abstract][Full Text] [Related]
4. Imaging case of the month. Pulmonary lymphangitic carcinomatosis from adenocarcinoma of the prostate.
Miller KS; Miller JM
Md Med J; 1994 Nov; 43(11):989-90. PubMed ID: 7808204
[No Abstract] [Full Text] [Related]
5. Docetaxel-induced hypersensitivity pneumonitis mimicking lymphangitic carcinomatosis in a patient with metastatic adenocarcinoma of the lung.
Taj A
Hematol Oncol Stem Cell Ther; 2013; 6(3-4):117-9. PubMed ID: 24096092
[TBL] [Abstract][Full Text] [Related]
6. Erdheim-Chester disease with lung involvement mimicking pulmonary lymphangitic carcinomatosis.
Yahng SA; Kang HH; Kim SK; Lee SH; Moon HS; Lee BY; Kim HS; Seo EJ
Am J Med Sci; 2009 Apr; 337(4):302-4. PubMed ID: 19365181
[TBL] [Abstract][Full Text] [Related]
7. Case report: lymphangitic carcinomatosis from cervical carcinoma--an unusual presentation of diffuse interstitial lung disease.
Perez-Lasala G; Cannon DT; Mansel JK; McGehee RP; Allen KG
Am J Med Sci; 1992 Mar; 303(3):174-6. PubMed ID: 1595780
[TBL] [Abstract][Full Text] [Related]
8. Lymphangitic carcinomas of the lung as presentation of prostatic cancer. A case report.
Miseria S; Torresi U; Menichetti ET; Tummarello D; Baldelli S; Murer B; Cellerino R
Tumori; 1991 Feb; 77(1):86-9. PubMed ID: 1826799
[TBL] [Abstract][Full Text] [Related]
9. Fluorodeoxyglucose positron emission tomography pattern of pulmonary lymphangitic carcinomatosis.
Digumarthy SR; Fischman AJ; Kwek BH; Aquino SL
J Comput Assist Tomogr; 2005; 29(3):346-9. PubMed ID: 15891505
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary lymphangitic carcinomatosis (PLC): spectrum of FDG-PET findings.
Acikgoz G; Kim SM; Houseni M; Cermik TF; Intenzo CM; Alavi A
Clin Nucl Med; 2006 Nov; 31(11):673-8. PubMed ID: 17053382
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific Membrane Antigen Positron Emission Tomography in the Staging of Newly Diagnosed Prostate Cancer: Is More Sensitivity Always Better?
Varatharajan A; Olivier T; Prasad V
Eur Urol; 2023 Jun; 83(6):481-483. PubMed ID: 36774222
[TBL] [Abstract][Full Text] [Related]
12. 18F-flouro-2-deoxyglucose positron emission tomography/computed tomography imaging of solitary prostatic and pulmonary tuberculosis mimicking metastatic prostate cancer.
Kadihasanoglu M; Yildiz T; Atahan S; Ausmus A; Atahan O
J Cancer Res Ther; 2015; 11(3):663. PubMed ID: 26458688
[TBL] [Abstract][Full Text] [Related]
13. Flourodeoxyglucose positron emission tomography scan may be helpful in the case of ductal variant prostate cancer when prostate specific membrane antigen ligand positron emission tomography scan is negative.
McEwan LM; Wong D; Yaxley J
J Med Imaging Radiat Oncol; 2017 Aug; 61(4):503-505. PubMed ID: 28349676
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary lymphangitic carcinomatosis without concurrent liver metastasis from colon cancer detected using 18F-FDG PET/CT: A case report.
Wang Y; Su M; Li L
Medicine (Baltimore); 2019 Oct; 98(41):e17446. PubMed ID: 31593099
[TBL] [Abstract][Full Text] [Related]
15. Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography for staging of high-risk prostate cancer.
Petersen LJ; Zacho HD
Scand J Urol; 2017 Dec; 51(6):498-501. PubMed ID: 28748722
[No Abstract] [Full Text] [Related]
16. Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials.
Smith CP; Xiang M; Armstrong WR; Nickols NG; Steinberg ML; Reiter RE; Rettig M; Weiner AB; Shen J; Valle L; Czernin J; Calais J; Kishan AU
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1079-1084. PubMed ID: 36863416
[No Abstract] [Full Text] [Related]
17. The Role of Positron Emission Tomography With (68)Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy.
Rai BP; Baum RP; Patel A; Hughes R; Alonzi R; Lane T; Adshead J; Vasdev N
Urology; 2016 Sep; 95():11-5. PubMed ID: 26790588
[TBL] [Abstract][Full Text] [Related]
18. Role of Prostate-Specific Membrane Antigen PET in Metastatic Prostate Cancer: We Have the Answers.
Pomykala KL; Herrmann K; Padhani AR; Hofman MS; Lalumera E; Fanti S
J Nucl Med; 2022 Oct; 63(10):1480-1481. PubMed ID: 35680413
[No Abstract] [Full Text] [Related]
19. Pulmonary lymphangitic carcinomatosis from squamous cell carcinoma of the cervix.
Kanthan R; Senger JL; Diudea D
World J Surg Oncol; 2010 Dec; 8():107. PubMed ID: 21129213
[TBL] [Abstract][Full Text] [Related]
20. 68Ga-Prostate-Specific Membrane Antigen Uptake in a Malignant Pleural Effusion From Metastatic Prostate Cancer After Pleurodesis.
Sachpekidis C; Alberts I; Rominger A; Afshar-Oromieh A
Clin Nucl Med; 2019 Oct; 44(10):838-839. PubMed ID: 31283614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
